Company: STAA
Filing Date: 2025-10-22
Form Type: DFAN14A
Source: 0001213900-25-101288
Chunk: 5

Company: STAAR SURGICAL CO
Filing Date: 2025-10-22
Form: DFAN14A
Chunk 5
---
27.5% of the outstanding
common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), notified the Company’s
Board of Directors (the “Board”) yesterday that it intends to call a Special Meeting of STAAR shareholders for the purpose
of removing several directors.

Neal C. Bradsher, Broadwood Founder and President, said:

“We informed the Board yesterday of our intention to
call a Special Meeting of shareholders for the purpose of removing several directors in light of the overwhelming opposition to the proposed
acquisition of STAAR by Alcon.

We once again caution the Board against taking any steps
to delay a vote on the proposed transaction or making any last-minute changes to the transaction without substantial input from and alignment
with shareholders.

It is clear to us that the Board no longer has the confidence
of shareholders, and that new directors are needed to properly steward the Company and restore shareholder trust.

We anticipate that a refreshed Board would consider, among
other matters, how to run a full, fair, independent, and open strategic alternatives process to maximize value that is untainted by the
process issues and conflicts of interest that afflicted this proposed transaction with Alcon.”

Broadwood encourages its fellow shareholders to review its materials
at www.LetSTAARShine.com and
to vote on the GREEN Proxy Card “AGAINST” the proposed acquisition of STAAR by Alcon
Inc.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood
Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher,
Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”) are participants
in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders scheduled for October
23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special Meeting”). The Participants
have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GREEN Proxy
Card to be used in connection with any such solicitation of proxies from the Company’s shareholders for the Special Meeting. SHAREHOLDERS OF STAAR ARE URGED